NWU Institutional Repository

Carbamate substituted 2-amino-4,6-diphenylpyrimidines as adenosine receptor antagonists

Abstract

A novel series of carbamate substituted 2-amino-4,6-diphenylpyrimidines was evaluated as potential dual adenosine A1 and A2A receptor antagonists. The majority of the synthesised compounds exhibited promising dual affinities, with A1Ki values ranging from 0.175 to 10.7 nM and A2AKi values ranging from 1.58 to 451 nM. The in vivo activity illustrated for 3-(2-amino-6-phenylpyrimidin-4-yl)phenyl morpholine-4-carboxylate (4c) is indicative of the potential of these compounds as therapeutic agents in the treatment of Parkinson’s disease, although physicochemical properties may require optimisation

Description

Citation

Robinson, S.J. et al. 2016. Carbamate substituted 2-amino-4,6-diphenylpyrimidines as adenosine receptor antagonists. Bioorganic & medicinal chemistry letters, 26:734-738. [https://doi.org/10.1016/j.bmcl.2016.01.004]

Endorsement

Review

Supplemented By

Referenced By